Omalizumab and COVID-19 treatment: Could it help?

Abdelmaksoud, Ayman; Goldust, Mohamad; Vestita, Michelangelo

Abdelmaksoud, Ayman; Goldust, Mohamad; Vestita, Michelangelo.

Abdelmaksoud A; Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
Goldust M; Department of Dermatology, University of Rome G. Marconi, Rome, Italy.
Vestita M; Department of Dermatology, University Medical Center Mainz, Mainz, Germany.

Dermatol Ther ; 33(4): e13792, 2020 Jul.

Article in English | MEDLINE | ID: covidwho-767361

Subject(s)

Betacoronavirus; Coronavirus Infections/epidemiology; Omalizumab/therapeutic use; Pneumonia, Viral/epidemiology; Urticaria/drug therapy; Anti-Allergic Agents/therapeutic use; COVID-19; Comorbidity; Humans; Pandemics; SARS-CoV-2; Urticaria/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Urticaria / Coronavirus Infections / Omalizumab / Betacoronavirus Type of study: Observational study Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.13792

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google